Home > Balance Sheet > AUROBINDO PHARMA

AUROBINDO PHARMA
Contingent Liabilities

    Back to Balance Sheet
AUROBINDO PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year Contingent Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Contingent Liabilities ₹368 Cr₹311 Cr₹159 Cr₹158 Cr₹141 Cr

What is the latest Contingent Liabilities ratio of AUROBINDO PHARMA ?

The latest Contingent Liabilities ratio of AUROBINDO PHARMA is ₹368 Cr based on Mar2025 Consolidated results.
Year Contingent Liabilities
Mar2025₹368 Cr
Mar2024₹311 Cr
Mar2023₹159 Cr
Mar2022₹158 Cr
Mar2021₹141 Cr

How is Contingent Liabilities of AUROBINDO PHARMA Trending?

Years Contingent Liabilities % Change
Mar2025 ₹368 Cr
18.28
Mar2024 ₹311 Cr
96.39
Mar2023 ₹159 Cr
0.50
Mar2022 ₹158 Cr
12.01
Mar2021 ₹141 Cr -

Compare Contingent Liabilities of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹68,604.1 Cr -2.6% -2.8% -6.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹412,626.0 Cr -1% -4.9% -7.6% Stock Analytics
DIVIS LABORATORIES ₹169,758.0 Cr -1.6% -0.4% 9.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹130,021.0 Cr 0.2% 2.8% 12.2% Stock Analytics
CIPLA ₹122,046.0 Cr 1% -0.9% -1% Stock Analytics
DR REDDYS LABORATORIES ₹106,086.0 Cr 0.4% 0.9% -8.9% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

-2.6%

-2.8%

-6.6%

SENSEX

-0.4%

-0.6%

8.6%


You may also like the below Video Courses